Corporate

Said Darwazah, Chairman and CEO of Hikma, awarded Global Generics “Leader of the Year”

London, 12 October 2016 – Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody’s / BB+ S&P, both stable), the fast growing multinational pharmaceutical group, announce that Said Darwazah, Chairman and Chief Executive Officer of the Group has received the “Leader of the Year Award” at the Third Global Generics and Biosimilars Awards held in Barcelona on 4 October 2016. The award was given in recognition of Said Darwazah’s distinguished leadership and vision.

Said Darwazah, Chairman and Chief Executive Officer of Hikma, said: “I am delighted and honoured to receive this award. The combined contributions of all of Hikma’s employees across our global markets have helped to drive strong growth and performance and, most importantly, to continue delivering high-quality affordable generic and branded generic medicines to patients in need.”